PATHOGENESIS, ETIOLOGY, TREATMENT, AND PREVENTION OF ATHEROSCLEROSIS IN ISCHEMIC HEART DISEASE
Main Article Content
Abstract
Ischemic Heart Disease (IHD) remains a leading cause of death and disability worldwide, largely due to atherosclerosis—a persistent inflammatory condition affecting arterial walls, driven by abnormal lipid metabolism and endothelial injury. This article examines the etiological factors of atherosclerosis, describes the stepwise cellular and molecular mechanisms of plaque development, and reviews contemporary therapeutic and preventive strategies aimed at slowing or halting coronary artery disease progression.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Libby P. Inflammation in vascular disease. Nature Reviews Cardiology, 2021.
Lusis AJ. Atherosclerosis. Nature, 2000.
Fuster V, Gotto AM. Vulnerable plaques in atherosclerosis. American Heart Association Journals, 2019.
Yusuf S et al. Modifiable risk factors and cardiovascular outcomes. The Lancet, 2020.
2.Heusch, G. (2020). Myocardial Ischemia: Lack of Coronary Blood Flow or Myocardial Oxygen Deficiency? Circulation Research, 126(10), 1406–1420.